James McIlroy is the founder of EnteroBiotix. EnteroBiotix has raised $34M in total funding. Latest round: Series B. Based in Aberdeen, Scotland.
James McIlroy is the CEO of EnteroBiotix, a clinical-stage biotechnology company focused on developing microbiome therapeutics. The company recently completed a £27m ($34m USD) funding round to advance its lead product candidate, EBX-102-02, through a Phase 2 clinical trial for Irritable Bowel Syndrome and progress its pipeline for other conditions such as liver cirrhosis and hepatic encephalopathy.
Full founder directory · Investor directory · Company funding database · Fundraising library